Musa Tariq Guardant Health, Inc. (GH) insider trading activity

Musa Tariq is Director of Guardant Health, Inc.. Currently has a direct ownership of 7,458 shares of GH, which is worth approximately $410,935. The most recent transaction as insider was on Aug 19, 2025, when has been sold 116 shares (Common Stock) at a price of $59.02 per share, resulting in proceeds of $6,846. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.46K

114.37% 3M change

75.61% 12M change

Total Value Held $410,935

Musa Tariq Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 19 2025	SELL Open market or private sale	$6,846 $59.02 p/Share	116 Reduced 1.53%	7,458 Common Stock
Aug 15 2025	BUY Exercise of conversion of derivative security	-	250 Added 3.2%	7,574 Common Stock
Jul 17 2025	SELL Open market or private sale	$5,591 $48.2 p/Share	116 Reduced 1.56%	7,324 Common Stock
Jul 15 2025	BUY Exercise of conversion of derivative security	-	250 Added 3.25%	7,440 Common Stock
Jun 18 2025	SELL Open market or private sale	$158,947 $49.47 p/Share	3,213 Reduced 30.89%	7,190 Common Stock
Jun 15 2025	BUY Exercise of conversion of derivative security	-	250 Added 2.35%	10,403 Common Stock
Jun 12 2025	BUY Exercise of conversion of derivative security	-	6,674 Added 39.66%	10,153 Common Stock
May 19 2025	SELL Open market or private sale	$4,644 $40.04 p/Share	116 Reduced 3.23%	3,479 Common Stock
May 15 2025	BUY Exercise of conversion of derivative security	-	250 Added 6.5%	3,595 Common Stock
Apr 17 2025	SELL Open market or private sale	$5,195 $44.79 p/Share	116 Reduced 3.35%	3,345 Common Stock
Apr 15 2025	BUY Exercise of conversion of derivative security	-	250 Added 6.74%	3,461 Common Stock
Mar 19 2025	SELL Open market or private sale	$5,069 $43.7 p/Share	116 Reduced 3.49%	3,211 Common Stock
Mar 15 2025	BUY Exercise of conversion of derivative security	-	249 Added 6.96%	3,327 Common Stock
Feb 20 2025	SELL Open market or private sale	$5,606 $48.33 p/Share	116 Reduced 3.63%	3,078 Common Stock
Feb 15 2025	BUY Exercise of conversion of derivative security	-	250 Added 7.26%	3,194 Common Stock
Jan 17 2025	SELL Open market or private sale	$4,359 $37.58 p/Share	116 Reduced 3.79%	2,944 Common Stock
Jan 15 2025	BUY Exercise of conversion of derivative security	-	250 Added 7.55%	3,060 Common Stock
Dec 18 2024	SELL Open market or private sale	$4,042 $34.85 p/Share	116 Reduced 3.96%	2,810 Common Stock
Dec 15 2024	BUY Exercise of conversion of derivative security	-	250 Added 7.87%	2,926 Common Stock
Dec 13 2024	SELL Open market or private sale	$81,200 $35.0 p/Share	2,320 Reduced 46.44%	2,676 Common Stock
Nov 15 2024	BUY Exercise of conversion of derivative security	-	250 Added 4.77%	4,996 Common Stock
Oct 15 2024	BUY Exercise of conversion of derivative security	-	250 Added 5.0%	4,746 Common Stock
Sep 15 2024	BUY Exercise of conversion of derivative security	-	249 Added 5.25%	4,496 Common Stock
Aug 15 2024	BUY Exercise of conversion of derivative security	-	250 Added 5.56%	4,247 Common Stock
Jul 15 2024	BUY Exercise of conversion of derivative security	-	250 Added 5.89%	3,997 Common Stock

Musa Tariq

Director

Palo Alto, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GH shares.

Notify only if

Value

Insider Trading

Get notified when an Guardant Health, Inc. insider buys or sells GH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Guardant Health, Inc.

Track Activities on GH

Account